Moximed Inc, a developer of unicompartmental load absorber implants for active patients with painful knee osteoarthritis, has raised $50 million in Series C funding. The company’s investors include Advent Life Sciences, Future Fund, NEA, Morgenthaler Ventures, GBS Venture Partners and Vertex Healthcare.